Hong Kong REITS Stock News

Viva Biotech Holdings closed at HK$1.435 on Thursday, roughly flat over the past month after a soft 7 day patch. Traders appear cautious. The headline from the half year update is not the revenue line, which came in at C¥1,006.5m, but the pressure on profitability and quality of earnings. Net profit margin over the past 12 months sat at 9.4% and relied on a sizeable C¥103.3m one off gain. For anyone with a multi year horizon, the key question now is how sustainable that earnings base is once...

Asia Tele-Net and Technology stock has been on a short streak, with the share price up over the past week and month. Today’s H1 2026 earnings, however, highlight why the story still carries risk. The company delivered revenue of HK$423.9 million but remained in the red with a net loss of HK$19.4 million and negative basic earnings per share. The key headline for this release is valuation strain. The stock trades on a P/S multiple more than three times the wider Hong Kong machinery industry...

Hansoh Pharmaceutical Group stock has been on a tear, up roughly 17% over the past three months. Today’s earnings story is less about momentum and more about profitability power. The market closed with Hansoh at HK$36.82, while the latest half year numbers underline a business that is earning hard cash on its science. The headline is margin strength. Hansoh reported H1 2026 net income of CNY 4,257.9m on revenue of CNY 8,304.0m, which reinforces a trailing net margin of about 42%. For a drug...

Town Health International Medical Group stock closed at HK$0.186 after the latest half year results, with investors already sitting on a mixed run that includes a 90 day decline of about 12%. The headline from these earnings is simple. The company stayed in the black with basic earnings per share of HK$0.0019 in H1 2026, yet the valuation still looks stretched on a P/E of 86.6x. For a healthcare operator once associated with losses, that gap between thin profits and a premium multiple is now...

CSPC Pharmaceutical Group (SEHK:1093) is back in focus after reporting half year 2026 results, announcing a higher interim dividend and updating investors on several oncology drug milestones in China. The recent half year 2026 earnings and oncology updates appear to have fed directly into CSPC Pharmaceutical Group’s share price momentum, with a 90 day share price return of 36.85% and a 30 day gain of 14.76% helping lift the stock to HK$9.525. The 3 year total shareholder return of 81.14%...

Shareholders might have noticed that Sinopharm Group Co. Ltd. ( HKG:1099 ) filed its interim result this time last...

It looks like Yoho Group Holdings Limited ( HKG:2347 ) is about to go ex-dividend in the next 4 days. Typically, the...

Sunny Optical earnings jump puts recent share performance in focus Sunny Optical Technology (Group) (SEHK:2382) reported half year 2026 sales of CNY 21,905.7 million and net income of CNY 1,808.36 million, with basic earnings per share from continuing operations at CNY 1.6803. The earnings update has come alongside a short burst of positive momentum for Sunny Optical Technology (Group), with a 1 day share price return of 2.46% and a 7 day share price return of 7.19%. However, the 1 year total...

As global markets navigate a complex landscape of elevated Treasury yields, geopolitical tensions, and fluctuating oil prices, investors are increasingly looking to diverse regions like Asia for potential opportunities. Within this context, penny stocks—despite their seemingly outdated name—remain an intriguing area of interest due to their potential for value and growth. These smaller or newer companies can offer unique opportunities when backed by strong financials, and this article will...

In recent months, Asian markets have experienced a mix of challenges and opportunities, with fluctuating economic indicators and geopolitical tensions influencing investor sentiment. Amidst this backdrop, dividend stocks in Asia stand out as a potential source of steady income for investors seeking stability in uncertain times.

Insiders who acquired HK$3.64m worth of Yee Hop Holdings Limited's ( HKG:1662 ) stock at an average price of HK$2.80 in...

Why Genscript Biotech’s Latest Earnings Matter For Investors Genscript Biotech (SEHK:1548) reported half year 2026 results that showed sales of US$404.22 million compared with US$518.77 million a year earlier, while net loss widened to US$129.34 million from US$25.46 million. The latest earnings come after a strong run in Genscript Biotech’s share price, with a 30 day share price return of 110.11% and a 90 day return of 153.15%, while the 1 year total shareholder return of 103.81% points to...

With the business potentially at an important milestone, we thought we'd take a closer look at CStone Pharmaceuticals...

Why TUHU Car’s Half Year 2026 Earnings Matter Now TUHU Car (SEHK:9690) has just reported half year 2026 results, with sales of CNY 8,777.82 million and net income of CNY 184.44 million. Earnings per share from continuing operations were CNY 0.2 diluted. At a latest share price of HK$11.95, TUHU Car has seen a 1-day share price return of 4.82% and a 7-day share price return of 2.40%. However, the year to date share price return is down 25.55% and the 1-year total shareholder return has...

China Electronics Optics Valley Union Holding closed at HK$0.154 on Wednesday, with the stock under pressure in recent months. The headline from these H1 2026 results is a clear profit squeeze. Revenue came in at ¥1,254.705m, yet the company swung back into a loss, reporting net income from ongoing operations that turned negative and basic earnings per share back in the red. For a real estate focused group already carrying weak interest coverage and an uncovered dividend, this return to...

Tencent Holdings (SEHK:700) has moved further into next generation AI hardware through its lead investment in Xpeng’s Dogotix humanoid robotics unit, while also continuing sizeable share repurchases backed by recent earnings strength. Tencent Holdings’ share price is HK$445.4, and the stock has risen 4.8% over the past 90 days, even though the year-to-date share price return is down 28.5%. The 3-year total shareholder return of 40.71% and 5-year total shareholder return of 3.03% point to a...

Even though Dimmi Life Holdings Limited ( HKG:1667 ) stock gained 10% last week, insiders who sold HK$47m worth of...

InnoCare Pharma Limited ( HKG:9969 ) last week reported its latest half-year results, which makes it a good time for...

It's been a pretty great week for China Overseas Grand Oceans Group Limited ( HKG:81 ) shareholders, with its shares...

Anyone interested in Pangaea Connectivity Technology Limited ( HKG:1473 ) should probably be aware that the Executive...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see The Hong Kong...

One thing we could say about the analysts on GenFleet Therapeutics (Shanghai) Inc. ( HKG:2595 ) - they aren't...

As you might know, China Resources Pharmaceutical Group Limited ( HKG:3320 ) last week released its latest half-year...

As Asian markets navigate a landscape marked by global economic uncertainties and fluctuating investor sentiment, dividend stocks have emerged as a compelling option for those seeking steady income. In this environment, identifying companies with strong fundamentals and reliable dividend histories can offer investors potential stability amid broader market volatility.